CIK 0001357459 · Non-accelerated filer<br>Smaller reporting company
PALISADE BIO, INC.
Sign in to watch- Ticker
- PALI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 522007292
- Phone
- (858) 704-4900
- Business address
- 7750 EL CAMINO REAL, SUITE 5200, CARLSBAD, CA, 92009
- Former names
- PALISADE BIO, INC., Seneca Biopharma, Inc., Neuralstem, Inc.
- Open-market buys, last 90 days
- $28,800
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$28,800. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-06 | Baltera Robert Jr. Director | Purchase | +20,000 | $2.05 | $41K | 386,904 |
| 2026-07-06 | Jones Mitchell Lawrence Chief Medical Officer | Option exercise | +131,167 | 145,889 | ||
| 2026-07-06 | Jones Mitchell Lawrence Chief Medical Officer | Option exercise · Restricted Stock Units | −131,167 | 655,833 | ||
| 2026-07-06 | Finley John David CEO, CFO | Option exercise | +335,167 | 364,353 | ||
| 2026-07-06 | Finley John David CEO, CFO | Option exercise · Restricted Stock Units | −335,167 | 1,675,833 | ||
| 2026-07-02 | Baltera Robert Jr. Director | Purchase | +10,000 | $1.98 | $20K | 366,904 |
| 2026-07-01 | Baltera Robert Jr. Director | Purchase | +20,000 | $1.98 | $40K | 356,904 |
| 2026-06-10 | Baltera Robert Jr. Director | Grant or award | +336,904 | 336,904 | ||
| 2026-06-10 | Wei Binxian Director | Grant or award | +592,300 | 593,155 | ||
| 2026-06-10 | Wei Binxian Director | Option exercise | +20,200 | 613,355 | ||
| 2026-06-10 | Wei Binxian Director | Option exercise · Restricted Stock Units | −20,200 | 40,400 | ||
| 2026-06-10 | Williams Donald Allen Director | Grant or award | +1,498,900 | 1,509,628 | ||
| 2026-06-10 | Williams Donald Allen Director | Option exercise | +60,666 | 1,570,294 | ||
| 2026-06-10 | Williams Donald Allen Director | Option exercise · Restricted Stock Units | −60,666 | 121,334 | ||
| 2026-06-10 | Chuang Emil Director | Grant or award | +592,300 | 592,300 | ||
| 2026-06-10 | Chuang Emil Director | Option exercise | +20,200 | 612,500 | ||
| 2026-06-10 | Chuang Emil Director | Option exercise · Restricted Stock Units | −20,200 | 40,400 | ||
| 2026-06-10 | Zwick Jordan Michael Director | Grant or award | +336,904 | 336,904 | ||
| 2026-02-12 | Jones Mitchell Lawrence Chief Medical Officer | Sale | −1,989 | $1.75 | $3K | 13,263 |
| 2026-02-12 | Finley John David CEO, CFO | Sale | −3,896 | $1.75 | $7K | 27,353 |
Page 2 of 12 · 233 trades